annual cash & cash equivalents:
$174.96M+$47.85M(+37.65%)Summary
- As of today (June 17, 2025), DNLI annual cash & cash equivalents is $174.96 million, with the most recent change of +$47.85 million (+37.65%) on December 31, 2024.
- During the last 3 years, DNLI annual cash & cash equivalents has fallen by -$118.52 million (-40.38%).
- DNLI annual cash & cash equivalents is now -65.50% below its all-time high of $507.14 million, reached on December 31, 2020.
Performance
DNLI Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$56.95M-$118.01M(-67.45%)Summary
- As of today (June 17, 2025), DNLI quarterly cash & cash equivalents is $56.95 million, with the most recent change of -$118.01 million (-67.45%) on March 31, 2025.
- Over the past year, DNLI quarterly cash & cash equivalents has dropped by -$3.63 million (-5.99%).
- DNLI quarterly cash & cash equivalents is now -88.77% below its all-time high of $507.14 million, reached on December 31, 2020.
Performance
DNLI quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DNLI Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.6% | -6.0% |
| 3 y3 years | -40.4% | -45.7% |
| 5 y5 years | +120.2% | -72.6% |
DNLI Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.4% | +37.6% | -73.9% | at low |
| 5 y | 5-year | -65.5% | +120.2% | -88.8% | at low |
| alltime | all time | -65.5% | +469.2% | -88.8% | +72.1% |
DNLI Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $56.95M(-67.5%) |
| Dec 2024 | $174.96M(+37.6%) | $174.96M(+93.0%) |
| Sep 2024 | - | $90.64M(+21.4%) |
| Jun 2024 | - | $74.68M(+23.3%) |
| Mar 2024 | - | $60.57M(-52.3%) |
| Dec 2023 | $127.11M(-41.7%) | $127.11M(-14.1%) |
| Sep 2023 | - | $148.01M(+12.2%) |
| Jun 2023 | - | $131.97M(+93.7%) |
| Mar 2023 | - | $68.13M(-68.8%) |
| Dec 2022 | $218.04M(-25.7%) | $218.04M(+83.8%) |
| Sep 2022 | - | $118.61M(-23.5%) |
| Jun 2022 | - | $155.09M(+47.8%) |
| Mar 2022 | - | $104.95M(-64.2%) |
| Dec 2021 | $293.48M | $293.48M(-25.6%) |
| Sep 2021 | - | $394.55M(-18.8%) |
| Jun 2021 | - | $485.68M(+11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $435.32M(-14.2%) |
| Dec 2020 | $507.14M(+538.3%) | $507.14M(+44.5%) |
| Sep 2020 | - | $351.05M(+155.9%) |
| Jun 2020 | - | $137.18M(-33.9%) |
| Mar 2020 | - | $207.54M(+161.2%) |
| Dec 2019 | $79.45M(+3.0%) | $79.45M(-3.9%) |
| Sep 2019 | - | $82.67M(+31.4%) |
| Jun 2019 | - | $62.94M(+58.7%) |
| Mar 2019 | - | $39.66M(-48.6%) |
| Dec 2018 | $77.12M(-64.7%) | $77.12M(+76.7%) |
| Sep 2018 | - | $43.65M(+31.9%) |
| Jun 2018 | - | $33.09M(-24.8%) |
| Mar 2018 | - | $44.00M(-79.9%) |
| Dec 2017 | $218.38M(+448.0%) | $218.38M(+502.1%) |
| Sep 2017 | - | $36.27M(-9.0%) |
| Dec 2016 | $39.85M(+29.6%) | $39.85M |
| Dec 2015 | $30.74M | - |
FAQ
- What is Denali Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Denali Therapeutics?
- What is Denali Therapeutics annual cash & cash equivalents year-on-year change?
- What is Denali Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Denali Therapeutics?
- What is Denali Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Denali Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of DNLI is $174.96M
What is the all time high annual cash & cash equivalents for Denali Therapeutics?
Denali Therapeutics all-time high annual cash & cash equivalents is $507.14M
What is Denali Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, DNLI annual cash & cash equivalents has changed by +$47.85M (+37.65%)
What is Denali Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DNLI is $56.95M
What is the all time high quarterly cash & cash equivalents for Denali Therapeutics?
Denali Therapeutics all-time high quarterly cash & cash equivalents is $507.14M
What is Denali Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, DNLI quarterly cash & cash equivalents has changed by -$3.63M (-5.99%)